According to a research report published earlier today, Jefferies has increased Acadia Healthcare's ACHC PT from $13 to $18.
In the report, Jefferies commented, "ACHC is one of the few companies in our coverage list with substantial growth characteristics. Through a combination of acute inpatient psychiatric bed expansion/conversions, improved pricing and operating efficiencies, and acquisitions, ACHC is well positioned to grow earnings north of 25% over the next 3-5 years. Reiterate Buy/$18PT (up from $13)."
Acadia Healthcare is currently trading at $14.99.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in